Record cases of gonorrhoea and syphilis across Europe signal a public health crisis driven by testing gaps, prevention failures, and surging transmission rates. The European Centre for Disease Prevention and Control reports historically high infection numbers, marking a concerning shift in STI epidemiology across the continent.
Gonorrhoea cases have climbed steadily, fueled partly by antimicrobial resistance that complicates treatment. The bacteria now shows reduced susceptibility to standard antibiotics, forcing clinicians toward expensive combination therapies and raising fears of untreatable strains emerging. Syphilis diagnoses spike even more sharply, with outbreaks clustering in major urban centers and among men who have sex with men, though heterosexual transmission accelerates in some regions.
Testing infrastructure cannot keep pace with demand. Many European nations lack accessible, affordable screening programs, leaving infections undiagnosed until symptomatic stages or transmission to partners occurs. Prevention campaigns have withered post-pandemic, and sexual health services face chronic underfunding. Healthcare workers report dwindling awareness among younger cohorts who came of age during COVID lockdowns, when routine clinic services contracted dramatically.
Delayed diagnosis compounds the damage. Untreated syphilis progresses to neurosyphilis and cardiovascular complications. Gonorrhoea spreads asymptomatically in women and trans individuals, enabling silent reservoir transmission. Both infections increase HIV acquisition risk significantly.
The ECDC calls for urgent investment in point-of-care testing, partner notification systems, and public education. Countries like the Netherlands and Sweden maintain lower rates through robust screening networks and harm-reduction focus, offering roadmaps for peers. Antibiotic stewardship efforts aim to slow resistance development, but without scaled access to preventive services and regular testing, European STI rates will likely remain elevated. The window for intervention narrows as resistance consolidates and stigma continues suppressing health-seeking behavior.